PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy
Aim. To investigate the correlation between PPP1R12A gene copy number and clinical outcomes of oxaliplatin-based regimen in stage III colorectal cancer (CRC). Methods. A total of 139 paraffin-embedded tissue samples of stage III CRC patients who received oxaliplatin-based treatment after radical sur...
Saved in:
Main Authors: | Chenbo Zhang (Author), Ajian Li (Author), Huaguang Li (Author), Kangsheng Peng (Author), Qing Wei (Author), Moubin Lin (Author), Zhanju Liu (Author), Lu Yin (Author), Jianwen Li (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma
by: Lijun Cheng, et al.
Published: (2019) -
Experience of copy number variation sequencing applied in spontaneous abortion
by: Yi-Fang Dai, et al.
Published: (2024) -
Ferroptosis: Reviewing CRC with the Third Eye
by: Liu X, et al.
Published: (2022) -
Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
by: Zhao Y, et al.
Published: (2021) -
Copy Number Variants in Epileptic Encephalopathy
by: J Gordon Millichap
Published: (2012)